Table 4.
Partial correlation coefficients of different parameters in patients with Kawasaki disease
| S100A12 | sRAGE | Resistin × S100A12 | Resistin/sRAGE | S100A12/sRAGE | WBCs | N | CRP | |
|---|---|---|---|---|---|---|---|---|
| Resistin | 0.552*** | -0.507*** | 0.889*** | 0.866*** | 0.696*** | 0.500*** | 0.695*** | 0.613*** |
| S100A12 | -0.252* | 0.777*** | 0.376** | 0.734*** | 0.339*** | 0.347*** | 0.321** | |
| sRAGE | -0.374*** | -0.575*** | -0.547*** | -0.533*** | -0.614*** | -0.566*** | ||
| S100A12 × Resistin | 0.701*** | 0.771*** | 0.385*** | 0.530*** | 0.448*** | |||
| Resistin/sRAGE | 0.782*** | 0.542*** | 0.734*** | 0.668*** | ||||
| S100A12/sRAGE | 0.529*** | 0.609*** | 0.567*** | |||||
| WBCs | 0.523*** | 0.449*** | ||||||
| N | 0.639*** |
sRAGE, soluble receptor for advanced glycation end products; WBCs, white blood cells; N, neutrophils; CRP, C-reactive protein. Control variables were age and gender. *Correlation significant at the 0.05 level (2-tailed); **correlation significant at the 0.01 level (2-tailed); ***correlation significant at the 0.001 level (2-tailed).